Tag: 111

Ingredion 公布强劲的第二季度业绩，并上调全年业绩展望

韦斯特切斯特，伊利诺伊州, Aug. 03, 2025 (GLOBE NEWSWIRE) -- 作为全球领先的食品和饮料制造业配料解决方案供应商，Ingredion Incorporated（NYSE：INGR）今日公布其 2025 年第二季度业绩。

Ingredion Incorporated 第二季度業績表現穩健並提高全年展望

韋斯特切斯特，伊利諾州, Aug. 03, 2025 (GLOBE NEWSWIRE) -- 全球頂尖的食品和飲料製造行業原料方案供應商 Ingredion Incorporated (NYSE: INGR) 今天發布了 2025 年第二季度的業績報告。

イングレディオン・インコーポレーテッド (Ingredion Incorporated)、堅調な第2四半期の決算を報告し、通期見通しを上方修正

イリノイ州ウエストチェスタ, Aug. 03, 2025 (GLOBE NEWSWIRE) -- 食品飲料製造業を対象とした原材料ソリューションの世界トップクラスのプロバイダーであるイングレディオン・インコーポレーテッド (NYSE: INGR) は本日、2025年第2四半期の決算報告を行った。

Ingredion Incorporated Mencatat Prestasi Kukuh bagi Suku Kedua dan Menambah Baik Unjuran Tahunan

WESTCHESTER, Ill., Aug. 03, 2025 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), penyedia global terkemuka bagi penyelesaian ramuan untuk industri pembuatan makanan dan minuman, hari ini mengumumkan keputusan kewangan bagi suku kedua tahun 2025.

Ingredion Incorporated, 견조한 2분기 실적 발표 및 연간 전망 상향 조정

일리노이주 웨스트체스터, Aug. 03, 2025 (GLOBE NEWSWIRE) -- 식품 및 음료 제조업계에 각종 원료 솔루션을 공급하는 글로벌 리더 Ingredion Incorporated(NYSE: INGR)가 2025년 2분기 실적을 발표했다

BEACH ENERGY’S Q4 ACTIVITIES REPORT

Trading Symbol: NWX (TSX-V) VANCOUVER, BC, Aug. 1, 2025 /CNW/ - Newport Exploration Ltd ("Newport" or "the Company") provides an update for licences in the...

Avient Announces Second Quarter 2025 Results

Second quarter sales of $867 million reflect 2% growth over the prior year quarter and includes a favorable impact of 1% from foreign exchangeSecond...

Ingredion Incorporated Delivers Solid Second Quarter Results and Improves Full-Year Outlook

WESTCHESTER, Ill., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its 2025 second quarter results.

BrightSpring Health Services, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

LOUISVILLE, Ky., Aug. 01, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the second quarter ended June 30, 2025, and increased Revenue and Adjusted EBITDA¹ guidance.

ALTAGAS REPORTS STRONG SECOND QUARTER 2025 RESULTS

Robust Performance Across Platform Led by Midstream CALGARY, AB, Aug. 1, 2025 /CNW/ - AltaGas Ltd. ("AltaGas" or the "Company") (TSX: ALA) reported second quarter...

Adhesives and Sealants Market Size Worth USD 126.50 Bn by 2034 Driven by Green Construction and Automotive Trends

The global adhesives and sealants market size is expected to be worth USD 126.50 billion by 2034, increasing from USD 76.53 billion in 2025 and is growing at a CAGR of 5.75% from 2025 to 2034, fueled by green construction, EV adoption, and packaging innovations.

The global adhesives and sealants market size is expected to be worth USD 126.50 billion by 2034, increasing from USD 76.53 billion in 2025 and is growing at a CAGR of 5.75% from 2025 to 2034, fueled by green construction, EV adoption, and packaging innovations.

LUNDIN GOLD REPORTS EXCEPTIONAL DRILLING RESULTS AT FDNS AND FDN EAST WITH FDNS ADVANCING TOWARDS INTEGRATION INTO MINE PLAN

VANCOUVER, BC, July 31, 2025 /CNW/ - Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased...

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2025 and Cash Dividend

MECHANICSBURG, Pa., July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its...

Cooper Standard Raises Full Year Adjusted EBITDA Guidance as Second Quarter and First Half Results Exceed Expectations

NORTHVILLE, Mich., July 31, 2025 /PRNewswire/ -- Cooper-Standard Holdings Inc. (NYSE: CPS) today reported results for the second quarter 2025. ...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTags111

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress